This inventor holds 1 USPTO granted patent. Top assignee: National Health Research Institutes. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Charles Sia: Pioneering RSV Vaccine Development
Introduction: Charles Sia, an innovative inventor based in Zhunan Town, Taiwan, is recognized for his contributions to medical science, particularly in the field of virology. With a focus on human respiratory syncytial virus (RSV), Sia has developed significant innovations aimed at preventing RSV infections through advanced vaccine formulations.
Latest Patents: Sia holds one patent for a vaccine composition against RSV. This invention represents a breakthrough in vaccine technology, as it involves a replication-defective recombinant adenovirus that carries a nucleotide sequence encoding the F protein of RSV or a fragment thereof. The patent outlines a method of utilizing this vaccine composition to prevent diseases related to RSV infections, showcasing Sia's commitment to addressing critical public health challenges.
Career Highlights: Currently, Charles Sia is affiliated with the National Health Research Institutes. His work there has been instrumental in advancing research and development within the healthcare sector. Sia's dedication to innovation in vaccine development aligns with his broader career goals of improving health outcomes for vulnerable populations.
Collaborations: Throughout his career, Charles has collaborated with esteemed colleagues such as Yen-Hung Chow and Hsiao-Yun Shao. These partnerships underline the importance of teamwork in scientific research, highlighting how collaborative efforts can lead to groundbreaking discoveries and advancements in medical technologies.
Conclusion: Charles Sia's contributions to the fight against RSV through his patented vaccine composition exemplify the critical role of inventors in the realm of public health. His innovative approach to vaccine development not only reinforces the importance of scientific research but also promises to make significant strides in preventing RSV-related diseases. As Sia continues his work at the National Health Research Institutes, the potential for future innovations remains bright, paving the way for advancements that can benefit communities around the world.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile